We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current 0M26 market cap is 278.58M. The company's latest EPS is USD -3.5542 and P/E is -7.40.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 18.37M | 29.39M | 38.16M | 6.03M | 4.76M |
| Operating Income | -3.89M | 12.42M | 17.53M | -17.41M | -40.27M |
| Net Income | -1.98M | 13.3M | 15.8M | -17.1M | -40.83M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 95.72M | 125.29M | 166.56M | 140.38M | 234.3M |
| Total Liabilities | 51.74M | 38.86M | 24.69M | 16.37M | 145.58M |
| Total Equity | 43.99M | 86.42M | 141.88M | 124.01M | 88.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -285k | 10.09M | 22.68M | -12.88M | -18.16M |
| Investing | -19.3M | -209k | -26.5M | -20.22M | -711k |
| Financing | 30.49M | 19.79M | 12.84M | -4.45M | 120.59M |
| Market Cap | 278.58M |
| Price to Earnings Ratio | -7.40 |
| Price to Sales Ratio | 63.52 |
| Price to Cash Ratio | 1.97 |
| Price to Book Ratio | 3.41 |
| Dividend Yield | - |
| Shares Outstanding | 11.49M |
| Average Volume (1 week) | 5 |
| Average Volume (1 Month) | 18 |
| 52 Week Change | 0.00% |
| 52 Week High | 24.25 |
| 52 Week Low | 24.25 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Xoma Corp |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.xoma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
